MedPath

Comparing Radiological Tubal Blockage Versus Laparoscopic Salpingectomy in Infertile Women With Hydrosalpinx During in Vitro Fertilization Treatment

Not Applicable
Withdrawn
Conditions
IVF-ET
Hydrosalpinx
Interventions
Procedure: laparoscopic salpingectomy
Procedure: radiological tubal blockage
Registration Number
NCT03521128
Lead Sponsor
ShangHai Ji Ai Genetics & IVF Institute
Brief Summary

Hydrosalpinx (HX) has a detrimental effect on the rates of implantation, pregnancy, live delivery, and early pregnancy loss during in vitro fertilization (IVF). The effectiveness of radiological tubal blockage has not been compared with the standard treatment of laparoscopic salpingectomy in randomized trials. The investigators aim in this randomized trial to compare the live birth rate of radiological tubal blockage versus laparoscopic salpingectomy in infertility women with HX prior to frozen-thawed embryo transfer (FET). Eligible women will be recruited and randomized into one of the following two groups: (1) the radiological tubal blockage group and (2) the laparoscopic salpingectomy group. The primary outcome is the live birth rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Women aged 20-43 years at the time of IVF/ICSI treatment
  • Unilateral or bilateral HX visible on pelvic ultrasound or hysterosalpingogram
  • At least one frozen embryo or blastocyst available for transfer
Exclusion Criteria
  • A history of pelvic inflammatory disease within 6 months
  • HX that were already blocked proximally on hysterosalpingogram
  • Frozen pelvis from previous laparoscopy
  • Women with fibroids interfering with radiological tubal blockage
  • Undergoing preimplantation genetic testing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the laparoscopic salpingectomy grouplaparoscopic salpingectomy-
the radiological tubal blockage groupradiological tubal blockage-
Primary Outcome Measures
NameTimeMethod
live birth ratea live birth after 22 weeks gestation, through study completion, an average of 1 year

the rate of live births per cycle

Secondary Outcome Measures
NameTimeMethod
ectopic pregnancyectopic pregnancy during first trimester, up to 12 weeks

pregnancy outside the uterine cavity

birth weighta live birth after 22 weeks gestation, through study completion, an average of 1 year

birth weight of the baby delivered

implantation ratenumber of gestational sacs per embryo transferred at 6 weeks of pregnancy, up to 6 weeks

number of gestational sacs per embryo transferred

multiple pregnancymultiple pregnancy beyond gestation 12 weeks up to 12 weeks

more than one intrauterine sacs on scanning

clinical pregnancy ratepresence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy, up to 6 weeks

presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy

positive hCG levelA blood hCG test is performed 14 days after the FET, up to 14 days

defined with the result of serum β-hCG ≥10 mIU/mL.

ongoing pregnancy rateiable pregnancy beyond gestation 12 weeks, up to 12 weeks

presence of a fetal pole with pulsation at 12 weeks of gestation

miscarriage ratea clinically recognized pregnancy loss before the 22 weeks of pregnancy, up to 22 weeks

defined as a clinically recognized pregnancy loss before the 22 weeks of pregnancy. The denominator is the clinical pregnancy.

Trial Locations

Locations (1)

ShangHai JIAI Genetics&IVF Institute

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath